Bioventus Inc. SEC filings BVS

Bioventus Inc. has 463 filings in SEC EDGAR's recent list, going back to Apr 19, 2016. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 26, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Apr 22, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 22, 2025 —
DEF 14A Proxy statement Apr 22, 2025 Dec 31, 2024
DEFA14A Additional proxy material Jun 3, 2024 —
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 11, 2024
PRE 14A Preliminary proxy statement Apr 10, 2024 Jun 11, 2024
DEFA14A Additional proxy material Apr 27, 2023 —
DEF 14A Proxy statement Apr 27, 2023 Jun 7, 2023
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 17, 2022

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
BVS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Durham, NC
SEC filer status
Accelerated filer, Emerging growth company
SEC CIK
1665988

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.